Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02979782 : Neurological Outcome After Minimal Invasive Coronary Artery Bypass Graft
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Minimum age of 18

- Elective Endo-CABG procedure (group 1)

- Elective PCI procedure (group 2)

- Elective healthy volunteer

Exclusion Criteria:

- Medical history of:

- Postoperative cognitive dysfunction, delirium or cerebrovascular accident

- symptomatic carotid artery disease

- Dementia

- Renal dysfunction: glomular filtration rate (GFR) < 30 ml/min

- Hepatic dysfunction: serum glutamic-oxaloacetic transaminase (SGOT)/ aspartate
aminotransferase (AST), or serum glutamic-pyruvic transaminase (SGPT)/ alanine
aminotransferase (ALT), more than three timer higher than normal limits

- History of medication and alcohol abuse

- Language barrier or incapability to communicate

- Physical condition making participation impossible

- Participation in other clinical trials of a drug or medical instrument

- Surgical revision or intra-operative major cardial event (Endo-CABG group)

- Conversion to cardiac surgery or intra-operative major event (PCI group)
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02979782      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740